Mylan Fights Decision Blocking Generic Benicar
Mylan Pharmaceuticals Inc. is appealing a federal judge's decision to validate Daiichi Sankyo Co. Ltd.'s patent for the active ingredient in its hypertension drugs Benicar and Azor and to enjoin Mylan...To view the full article, register now.
Already a subscriber? Click here to view full article